Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
523200
Reference Type
Journal Article
Title
Molecular diagnosis of Fragile X syndrome
Author(s)
Sofocleous, C; Kolialexi, A; Mavrou, A
Year
2009
Is Peer Reviewed?
Yes
Journal
Expert Review of Molecular Diagnostics
ISSN:
1473-7159
EISSN:
1744-8352
Volume
9
Issue
1
Page Numbers
23-30
Language
English
DOI
10.1586/14737159.9.1.23
Abstract
Fragile X syndrome, the most prevalent inherited cause of mental retardation, is related to hyperexpansion of a polymorphic CGG repeat of the FMR1 gene. Expansion of 55-200 repeats are called premutations and characterize carriers who usually have no mental impairment. The disease causing full mutations exceed 200 CGG repeats, are hypermethylated and lead to transcriptional silencing of the gene and absence of the Fragile X mental retardation protein (FMRP). Diagnostic approaches involve molecular and immunocytochemical techniques. Southern blot, which allows mutations to be detected and methylation status to be determined in a single test, remains the procedure of choice for most laboratories. Modifications of PCR methods, including methylation specific PCR, are also proposed but their implementation is still in question because of inherent difficulties to amplify CGG repeats, distinguish between mosaic patterns and interpret results in female individuals. The FMRP antibody test is also suitable for large population screening and elucidation of Fragile X syndrome cases with no CGG expansion, but it is not widely applied. In search for novel diagnostic approaches, use of PCR as a first prescreening test followed by Southern blot is considered the most reliable procedure.
Keywords
FMR1 gene; FMRP; Fragile X syndrome; full mutation; ms-PCR; premutation; Southern blot analysis; full-mutation alleles; mentally-retarded males; rapid antibody-test; cgg repeat; tremor/ataxia syndrome; prenatal-diagnosis; capillary-electrophoresis; pcr amplification; fmr1 premutation; screening method
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity